(Q42945323)

English

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis

scientific article published on 3 August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 November 2017

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis (English)

1 reference

Europe PubMed Central

11 November 2017

meglumine antimoniate

1 reference

based on heuristic

inferred from title

Karen D Cowgill

object named as

Karen D Cowgill

12

0 references

13

object named as

Steven G Reed

1 reference

Europe PubMed Central

11 November 2017

7

object named as

Rhea N Coler

1 reference

Europe PubMed Central

11 November 2017

author name string

Evaldo Nascimento

1

1 reference

Europe PubMed Central

11 November 2017

Demetrios F Fernandes

2

1 reference

Europe PubMed Central

11 November 2017

Edva P Vieira

3

1 reference

Europe PubMed Central

11 November 2017

Antonio Campos-Neto

4

1 reference

Europe PubMed Central

11 November 2017

Jill A Ashman

5

1 reference

Europe PubMed Central

11 November 2017

Fabiana P Alves

6

1 reference

Europe PubMed Central

11 November 2017

Lisa Y Bogatzki

8

1 reference

Europe PubMed Central

11 November 2017

Stuart J Kahn

9

1 reference

Europe PubMed Central

11 November 2017

Anna Marie Beckmann

10

1 reference

Europe PubMed Central

11 November 2017

Samuel O Pine

11

1 reference

Europe PubMed Central

11 November 2017

Franco M Piazza

14

1 reference

Europe PubMed Central

11 November 2017

language of work or name

0 references

publication date

3 August 2010

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

28

1 reference

Europe PubMed Central

11 November 2017

40

1 reference

Europe PubMed Central

11 November 2017

6581-6587

1 reference

Europe PubMed Central

11 November 2017

Control of neglected tropical diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Leishmaniasis: current situation and new perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Controlled field trials of a vaccine against New World cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

A framework for assessing immunological correlates of protection in vaccine trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Potent stimulation of the innate immune system by a Leishmania brasiliensis recombinant protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Taking toll: lipid A mimetics as adjuvants and immunomodulators

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

THE CURATIVE VALUE OF LEISHMANIA CULTURE "VACCINE" IN ORIENTAL SORE.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Vaccine for prophylaxis and immunotherapy, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.063

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.07.063

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42945323&oldid=1974283150"